Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.445EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.445EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.1.445ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.445ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
B.1.1.445EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-1339.23China
B.1.1.445EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
B.1.1.445ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-1427.97China
B.1.1.445ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
AY.21 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.21 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.21 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.21 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.21 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.21 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.21 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.21 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.20EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.160.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.20ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.160.20ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.160.20EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.160.20EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.160.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.19EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.160.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.19ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.160.19ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.160.19EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.160.19EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.160.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.160.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.12ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.160.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.160.12EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.160.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.160.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AT.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
AT.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-2824.15Germany
AT.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
AT.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
AT.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
AT.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-4083.33China
AT.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used